Shilpa Medicare Limited Cash Flow Conversion Efficiency
Shilpa Medicare Limited cash flow conversion efficiency. Based on the latest financial reports, Shilpa Medicare Limited (SHILPAMED) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.01 Billion ≈ $21.76 Million USD) by net assets (Rs24.39 Billion ≈ $263.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shilpa Medicare Limited (2006–2025)
Cash flow conversion efficiency of Shilpa Medicare Limited from 2006 to 2025. This chart illustrates how Shilpa Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SHILPAMED share price today for real-time trading data and today's change.
Shilpa Medicare Limited Cash Flow Conversion Ratio Explained
Shilpa Medicare Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shilpa Medicare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shilpa Medicare Limited ranked by their cash flow conversion efficiency. Also see how much is Shilpa Medicare Limited worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Henan Dayou Energy Co Ltd
SHG:600403
|
0.002x |
|
Maanshan Iron & Steel Co Ltd
SHG:600808
|
-0.004x |
|
Shandong Iron and Steel Co Ltd
SHG:600022
|
0.016x |
|
Aecon Group Inc.
TO:ARE
|
0.062x |
|
Gränges AB (publ)
ST:GRNG
|
-0.026x |
|
Stora Enso Oyj A
HE:STEAV
|
0.007x |
|
Kajaria Ceramics Limited
NSE:KAJARIACER
|
0.074x |
|
Evergreen Aviation Tech Corp
TW:2645
|
0.059x |
Annual Cash Flow Conversion Efficiency for Shilpa Medicare Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Shilpa Medicare Limited from 2006 to 2025. Review cash generation quality of Shilpa Medicare Limited to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs23.64 Billion ≈ $255.63 Million |
Rs1.32 Billion ≈ $14.29 Million |
0.056x | -26.35% |
| 2024-03-31 | Rs18.00 Billion ≈ $194.66 Million |
Rs1.37 Billion ≈ $14.78 Million |
0.076x | -40.43% |
| 2023-03-31 | Rs17.74 Billion ≈ $191.89 Million |
Rs2.26 Billion ≈ $24.46 Million |
0.127x | +119.59% |
| 2022-03-31 | Rs18.11 Billion ≈ $195.87 Million |
Rs1.05 Billion ≈ $11.37 Million |
0.058x | +81.52% |
| 2021-03-31 | Rs14.67 Billion ≈ $158.70 Million |
Rs469.28 Million ≈ $5.08 Million |
0.032x | -65.85% |
| 2020-03-31 | Rs13.21 Billion ≈ $142.91 Million |
Rs1.24 Billion ≈ $13.38 Million |
0.094x | -24.09% |
| 2019-03-31 | Rs11.90 Billion ≈ $128.69 Million |
Rs1.47 Billion ≈ $15.87 Million |
0.123x | +196.51% |
| 2018-03-31 | Rs10.80 Billion ≈ $116.78 Million |
Rs449.20 Million ≈ $4.86 Million |
0.042x | +1.43% |
| 2017-03-31 | Rs9.14 Billion ≈ $98.83 Million |
Rs374.77 Million ≈ $4.05 Million |
0.041x | -77.31% |
| 2016-03-31 | Rs7.12 Billion ≈ $77.01 Million |
Rs1.29 Billion ≈ $13.92 Million |
0.181x | +47.44% |
| 2015-03-31 | Rs5.61 Billion ≈ $60.71 Million |
Rs688.06 Million ≈ $7.44 Million |
0.123x | -28.87% |
| 2014-03-31 | Rs4.06 Billion ≈ $43.96 Million |
Rs700.41 Million ≈ $7.57 Million |
0.172x | +29.97% |
| 2013-03-31 | Rs3.29 Billion ≈ $35.60 Million |
Rs436.38 Million ≈ $4.72 Million |
0.133x | -30.71% |
| 2012-03-31 | Rs2.81 Billion ≈ $30.37 Million |
Rs537.36 Million ≈ $5.81 Million |
0.191x | +5.31% |
| 2011-03-31 | Rs2.35 Billion ≈ $25.36 Million |
Rs426.13 Million ≈ $4.61 Million |
0.182x | -65.62% |
| 2010-03-31 | Rs1.01 Billion ≈ $10.95 Million |
Rs535.22 Million ≈ $5.79 Million |
0.528x | +4.69% |
| 2009-03-31 | Rs589.21 Million ≈ $6.37 Million |
Rs297.43 Million ≈ $3.22 Million |
0.505x | +307.88% |
| 2008-03-31 | Rs560.02 Million ≈ $6.06 Million |
Rs69.31 Million ≈ $749.54K |
0.124x | -39.79% |
| 2007-03-31 | Rs418.09 Million ≈ $4.52 Million |
Rs85.93 Million ≈ $929.33K |
0.206x | +203.23% |
| 2006-03-31 | Rs350.17 Million ≈ $3.79 Million |
Rs-69.72 Million ≈ $-753.98K |
-0.199x | -- |
About Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more